[The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death is underestimated].

作者信息

Disertori Marcello

机构信息

Cardiologia, Ospedale Santa Chiara, Trento.

出版信息

G Ital Cardiol (Rome). 2011 May;12(5):374-8; discussion 378. doi: 10.1714/643.7503.

DOI:10.1714/643.7503

PMID:21593957

Abstract

摘要

相似文献

[The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death is underestimated].

G Ital Cardiol (Rome). 2011 May;12(5):374-8; discussion 378. doi: 10.1714/643.7503.

[The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death should not restrict their use].

G Ital Cardiol (Rome). 2011 May;12(5):379-82; discussion 382. doi: 10.1714/643.7504.

Sudden death prevention with implantable devices.

Circulation. 2007 Jul 31;116(5):561-71. doi: 10.1161/CIRCULATIONAHA.106.655704.

Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

Arch Intern Med. 2009 Sep 14;169(16):1500-6. doi: 10.1001/archinternmed.2009.255.

Midterm experience with implantable cardioverter-defibrillators in children and young adults.

Europace. 2010 Dec;12(12):1732-8. doi: 10.1093/europace/euq340. Epub 2010 Sep 18.

A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.

J Am Coll Cardiol. 2008 Sep 30;52(14):1111-21. doi: 10.1016/j.jacc.2008.05.058.

The implantable cardioverter-defibrillator: does everybody need one?

Prog Cardiovasc Dis. 2001 Nov-Dec;44(3):169-94. doi: 10.1053/pcad.2001.29146.

Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients.

Europace. 2011 Mar;13(3):389-94. doi: 10.1093/europace/euq494. Epub 2011 Jan 5.

Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).

Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30.

Cost-effectiveness of implantable cardioverter-defibrillators.

N Engl J Med. 2005 Oct 6;353(14):1471-80. doi: 10.1056/NEJMsa051989.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验